On April 3, 2023 Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel, multifunctional biotherapeutics, reported that management will participate in the following upcoming investor conferences (Press release, Zymeworks, APR 3, 2023, View Source [SID1234629779]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

2023 Bloom Burton & Co. Healthcare Investor Conference. Zymeworks’ management will participate in one-on-one meetings and present on April 25th in Toronto, CA.

Stifel 2023 Targeted Oncology Days. Zymeworks’ management will participate virtually in one-on-one meetings and present on April 26th.

All presentations and webcasts will be available on Zymeworks’ website at View Source